Is ICU MEDICAL INC/DE (ICUI) Halal?

NASDAQ Healthcare United States $3.1B
✗ NOT HALAL
Confidence: 90/100
ICU MEDICAL INC/DE (ICUI) is Not Halal under AAOIFI Standard 21. The company's debt ratio of 40.9% exceeds the 30% threshold, indicating excessive interest-bearing debt relative to market capitalization. ICU MEDICAL INC/DE operates in the Healthcare sector.

Shariah Screening — 5 Standards

Based on financial data from December 2025

Standard Debt Ratio Cash Ratio Receivables Income Status
AAOIFI 40.9%
/ 30%
9.4%
/ 30%
6.3%
/ 30%
0.46%
/ 5%
✗ NOT HALAL
DJIM 40.9%
/ 33%
9.4%
/ 33%
6.3%
/ 33%
0.46%
/ 5%
✗ NOT HALAL
MSCI 32.9%
/ 33%
7.6%
/ 33%
5.0%
/ 33%
0.46%
/ 5%
✓ HALAL
S&P 40.9%
/ 33%
9.4%
/ 33%
6.3%
/ 33%
0.46%
/ 5%
✗ NOT HALAL
FTSE 32.9%
/ 33%
7.6%
/ 33%
5.0%
/ 50%
0.46%
/ 5%
✓ HALAL

Financial Highlights

P/E Ratio
6209.5
Forward: 13.5
EPS
$0.02
P/B Ratio
1.4
EV/EBITDA
13.2
EV: $4.1B
Revenue
$2.2B
Growth: -14.1%
Beta
0.8
Average volatility
Current Ratio
2.4

Profitability

Gross Margin 36.8%
Operating Margin 4.8%
Net Margin 0.0%
Return on Equity (ROE) 0.0%
Return on Assets (ROA) 1.7%

Cash Flow & Balance Sheet

Operating Cash Flow$180M
Free Cash Flow$83M
Total Debt$1.3B
Debt-to-Equity63.5
Current Ratio2.4
Total Assets$4.1B

Price & Trading

Last Close$127.65
50-Day MA$143.55
200-Day MA$134.50
Avg Volume272K
Beta0.8
52-Week Range
$107.00
$160.29

About ICU MEDICAL INC/DE (ICUI)

CEO
Mr. Vivek Jain
Employees
13,000
Sector
Healthcare
Industry
Medical Instruments & Supplies
Country
United States
Exchange
NASDAQ
Market Cap
$3.1B
Currency
USD

ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical products used in infusion therapy, vascular access, and vital care applications worldwide. It offers Clave needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoLock closed system transfer devices and ChemoClaveTM for preparation and administration of hazardous drugs; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; ClearGuard, SwabCap, and SwabTip disinfection caps; and vascular access products. The company provides IV therapy and diluents, such as sodium chloride, dextrose, balanced electrolyte solutions, lactated ringer's, ringer's, mannitol, sodium chloride/dextrose, and sterile water; and irrigation solutions comprising sodium chloride, sterile water irrigation, physiologic solutions, ringer's irrigation, acetic acid irrigation, glycine irrigation, sorbitol-mannitol irrigation, flexible containers, and pour bottle options. It offers infusion pumps under the Plum 360 and Plum Duo brands; ambulatory and syringe infusion hardware products; IV mediation safety software, including ICU Medical MedNet, an enterprise-class medication management platform; LifeShield and PharmGuard medication infusion safety software; hemodynamic monitoring products; anesthesia systems and devices, breathing circuits, ventilation, respiratory, and specialty airway products; temperature management solutions; anesthesia/pain management trays and components; and professional services. The company's customers include acute care hospitals, wholesalers, ambulatory clinics, and alternate site facilities, such as outpatient clinics, home health care providers, and long-term care facilities. ICU Medical, Inc. was founded in 1984 and is based in San Clemente, California.

Related Halal Stocks in Healthcare

Frequently Asked Questions

Is ICU MEDICAL INC/DE (ICUI) halal to invest in?

Based on our screening using AAOIFI Standard 21 (the strictest methodology), ICU MEDICAL INC/DE is Not Halal. The company fails one or more screening criteria. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.

What is ICU MEDICAL INC/DE's debt ratio?

ICU MEDICAL INC/DE's debt ratio is 40.9% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 32.9%.

What are ICU MEDICAL INC/DE's key financial metrics?

ICU MEDICAL INC/DE has a market capitalization of $3.1B, trailing P/E ratio of 6209.5, and revenue of $2.2B. The company maintains a gross margin of 36.8% and a net margin of 0.0%. Return on equity stands at 0.0%.

How often is the screening data updated?

Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.

Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.